News Releases

Date	Title	Additional Formats
July 18, 2024	Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults
May 28, 2024	Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
May 15, 2024	Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
May 9, 2024	Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
April 29, 2024	Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024
April 3, 2024	Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
March 26, 2024	Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
March 7, 2024	Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 29, 2024	Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
February 13, 2024	Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients